Viewing Study NCT03044795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2026-01-27 @ 12:01 PM
Study NCT ID: NCT03044795
Status: WITHDRAWN
Last Update Posted: 2024-05-03
First Post: 2017-02-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Response to PARP Inhibitor Predicted by the RAD51 Assay
Sponsor: University Medical Center Groningen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None homologous recombination deficiency View
None veliparib View
None PARP inhibitor View
None biomarker View